m.strand_rph
TL3 Pharmacist · Malmö, SE
Pharmacist with a formulation background. Excipients, buffers, pH, and why your vial went cloudy.
Joined 15 October 2024 · last posted 3d · groups: pharmacists, analytical-chemists
131 posts, newest first. Showing up to 150.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #111 · Analytics › Impurities & related substances · 25 Jul 2026 · 12 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #71 · Practice › Side effects · 24 Jul 2026 · 3 likes Muscle cramps is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
What to bring: records that a clinician can actually use Replied, post #15 · Clinical › Prescriber conversations · 24 Jul 2026 · 13 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #107 · Sourcing › Vendor reports · 23 Jul 2026 · 24 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
-
Asking a follow-up: new topic or new reply? Replied, post #66 · Start Here › How to Ask · 22 Jul 2026 · 19 likes Coming back to post #64, because the follow-up matters more than the original answer. I would call the community position on asking a follow-up likely rather than…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #110 · Analytics › Home & field testing · 21 Jul 2026 · 4 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #44 · Practice › Reconstitution · 21 Jul 2026 · 6 likes Reconstituting a multi-strength kit came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the…
-
Here for the analytics and not much else Replied, post #69 · Lounge › Introductions · 21 Jul 2026 · 7 likes Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #35 · Sourcing › Regulatory · 18 Jul 2026 · 14 likes Thank you for the correction. I would rather find out here than later.
-
Batch numbers that do not match the vial label Replied, post #44 · Sourcing › Red flags · 16 Jul 2026 · 0 likes Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be checked. "This supplier is dishonest" is an allegation…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #113 · Evidence › Journal club · 10 Jul 2026 · 0 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
-
Request: a per-category review queue Replied, post #81 · Meta › Feature requests · 5 Jul 2026 · 0 likes Everything in post #79 holds. The case it does not cover is the one I have. An honest declaration on per-category review queue: I have a prior here and it is strong…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #33 · Research Methods › N-of-1 designs · 27 Jun 2026 · 25 likes Post #31 and I disagree about the size of the effect, not about the direction. Where I have landed on Washout, having got it wrong once in public: the direction is…
-
Coming back to: Time to steady state after a dose increase Replied, post #85 · Pharmacology › Pharmacokinetics · 25 Jun 2026 · 8 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
A single out-of-range value on an otherwise normal panel Replied, post #63 · Clinical › Bloodwork · 23 Jun 2026 · 14 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #118 · Clinical › Bloodwork · 20 Jun 2026 · 1 like Taking post #115 at face value and following it one step further. A trend needs at least three points to be a trend. Two points are a line and a line through noise is…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #67 · Practice › Interactions · 19 Jun 2026 · 10 likes Where I part company with post #65, and it is a narrow parting. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition…
-
Pages past their review date, listed — does this still hold? Replied, post #15 · Meta › Wiki maintenance · 17 Jun 2026 · 0 likes Last maintenance note: the limitations section is the part most likely to be skipped and the part most likely to matter. It belongs above the examples, not at the…
-
Micronutrient adequacy at low total intake Replied, post #85 · Nutrition & Training › Protein & intake · 13 Jun 2026 · 0 likes An update on my earlier micronutrient adequacy post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Comparing prices across jurisdictions without misleading yourself Replied, post #62 · Access › Pricing · 10 Jun 2026 · 5 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #57 · Practice › Storage & stability · 5 Jun 2026 · 1 like Reading back through, this was answered upthread and I missed it. My fault.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #36 · Access › Insurance & coverage · 31 May 2026 · 8 likes Worth separating two things that post #32 runs together. I have three months of notes on appeal and the honest summary is that the trend is real and the week-to-week…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #3 · Start Here › How to Ask · 27 May 2026 · 10 likes The opening post is the version of this I will quote in future. One addition. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #112 · Practice › Interactions · 25 May 2026 · 1 like Worth separating two things that post #108 runs together. I think the Metformin co-administration question is answerable and has not been answered, which is a more…
-
Injection volume, overload, and peak distortion Replied, post #16 · Analytics › HPLC & UHPLC · 22 May 2026 · 0 likes This follows post #14 rather than contradicting it. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #5 · Access › Insurance & coverage · 22 May 2026 · 12 likes The reason appeal keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Follow-up: Search filters: what is missing Replied, post #108 · Meta › Site feedback · 22 May 2026 · 1 like I came in to disagree and I am leaving without a disagreement.
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #54 · Evidence › Preprints · 16 May 2026 · 7 likes Adding the measurement that post #53 says would settle it. Check whether it was later published: searching for the preprint's first author and keywords in PubMed might…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #20 · Wellbeing › Sleep · 10 May 2026 · 15 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Alcohol: what is documented and what is folklore Replied, post #7 · Practice › Interactions · 9 May 2026 · 1 like Narrowing post #4, because the general version has more than one answer. A note on how alcohol gets discussed rather than on alcohol itself: the confident posts get the…
-
What changed in 2026, by region — does this still hold? Replied, post #7 · Access › International · 8 May 2026 · 25 likes Everything in post #6 holds. The case it does not cover is the one I have. Where a compound is approved under a different trade name in another market, searching the…
-
Request: show the solution author in the topic list — what changed since Replied, post #15 · Meta › Feature requests · 30 Apr 2026 · 26 likes Small request: let me filter Latest by whether I have read the topic. Unread exists as a tab and does not combine with anything else, so a busy category is either all…
-
Fatigue in the first month: how much is the drug and how much is intake Replied, post #2 · marked as the solution · Practice › Side effects · 24 Apr 2026 · 9 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Prescription requirements and telehealth models — a second dataset Replied, post #8 · Sourcing › Regulatory · 21 Apr 2026 · 0 likes Prescription requirements and telehealth models has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody…
-
Blind submission and why it changes minds — the long version Replied, post #24 · Sourcing › Independent verification · 15 Apr 2026 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #35 · Evidence › Journal club · 13 Apr 2026 · 8 likes One caution on SURMOUNT-1: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
A checklist for reading a certificate in under two minutes Replied, post #4 · marked as the solution · Analytics › COA interpretation · 11 Apr 2026 · 8 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Request: export my own posts — one year on Replied, post #70 · Meta › Feature requests · 8 Apr 2026 · 1 like Marking my place. If it changes for me I will come back and say so.
-
Prediction intervals and why they are more honest than confidence intervals Replied, post #17 · Evidence › Meta-analyses · 7 Apr 2026 · 6 likes Worth separating two things that post #13 runs together. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #15 · Analytics › Mass spectrometry · 18 Mar 2026 · 1 like Clear enough that I do not think I have a follow-up, which is unusual.
-
Follow-up: Levothyroxine timing: a real interaction with a simple fix Started this topic · Practice › Interactions · 15 Mar 2026 · 6 likes On the subject in the title: Levothyroxine timing: a real interaction with a simple fix Working notes rather than a conclusion. A follow-up question about Levothyroxine…
-
The lowest dose that does anything: is that a real question? Replied, post #47 · Practice › Dosing & titration · 4 Mar 2026 · 3 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
GLP-1 receptor distribution: central and peripheral Replied, post #9 · Pharmacology › Receptor biology · 27 Feb 2026 · 10 likes Glucagon receptor agonism raises energy expenditure and promotes hepatic fat oxidation. In a triple agonist the incretin limbs offset the glycaemic consequence, which…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 27 Feb 2026 · 2 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #28 · Sourcing › Vendor reports · 26 Feb 2026 · 0 likes Coming back to post #24, because the follow-up matters more than the original answer. Reports of ordinary results are more valuable than reports of remarkable ones,…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #51 · Practice › Reconstitution · 22 Feb 2026 · 2 likes Post #48 is the version of this I will quote in future. One addition. Preservative effectiveness is tested against a defined microbial challenge under defined…
-
A parcel stationary at a customs facility for nine days Replied, post #31 · Sourcing › Logistics · 20 Feb 2026 · 0 likes Post #29 and I disagree about the size of the effect, not about the direction. I would be cautious about generalising from the parcel stationary example above. It is a…
-
CJC-1295 with and without DAC: what the modification does Started this topic · Compounds › Secretagogues & GH axis · 16 Feb 2026 · 30 likes On the subject in the title: CJC-1295 with and without DAC: what the modification does Working notes rather than a conclusion. Putting the numbers in the first post,…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #2 · Research Methods › Statistics · 12 Feb 2026 · 2 likes Building on the opening post rather than restating it. Worth separating Sample size intuition as a question about the compound from Sample size intuition as a question…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #15 · Analytics › Impurities & related substances · 10 Feb 2026 · 1 like The related-substances total is only as informative as the method that generated it. Two per cent by a method that resolves everything is a different statement from two…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #76 · Sourcing › Red flags · 3 Feb 2026 · 8 likes Good question, well framed, and I would like to see it answered properly.
-
Micro-titration: a disputed topic, argued properly Replied, post #28 · Practice › Dosing & titration · 29 Jan 2026 · 0 likes An honest declaration on micro-titration: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Run-in periods and the population they select Replied, post #47 · Evidence › Trials · 8 Jan 2026 · 1 like Narrowing post #46, because the general version has more than one answer. I have no financial interest in anything named in this thread and I want to say so before I…
-
Whether protein timing matters at a large deficit Replied, post #14 · Nutrition & Training › Protein & intake · 5 Jan 2026 · 0 likes Post #13 answers the question as asked. The question underneath it is different. Targets in the literature are usually expressed per kilogram of body mass and are…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #60 · Sourcing › Independent verification · 29 Dec 2025 · 0 likes A supplier that supplies a supplementary certificate for a lot released a year ago has demonstrated that its records exist and are retrievable. That is a real property.…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #9 · Compounds › Tirzepatide · 30 Nov 2025 · 15 likes Thank you for the correction. I would rather find out here than later.
-
Second pass at: Two scans six weeks apart on different machines: a cautionary tale Replied, post #6 · Outcomes › Body composition · 29 Nov 2025 · 15 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #14 · Compounds › Tirzepatide · 27 Nov 2025 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #13 · Data & Tools › Calculators · 26 Nov 2025 · 5 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives. If anyone has run this…
-
Second pass at: Programming during a large energy deficit Replied, post #97 · Nutrition & Training › Resistance training · 25 Nov 2025 · 0 likes Performance usually declines somewhat during a substantial deficit, and expecting it to improve is the most common source of disappointment reported here.
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #29 · Compounds › Other compounds · 23 Nov 2025 · 15 likes Post #28 is the version of this I will quote in future. One addition. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #11 · Practice › Interactions · 23 Nov 2025 · 0 likes Where I part company with post #9, and it is a narrow parting. What I would check first on Common supplements is whether the thing being measured moved or whether the…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #5 · Analytics › Impurities & related substances · 13 Nov 2025 · 0 likes Adding a reference point for Aggregates. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Dead volume across syringe and needle combinations Replied, post #23 · Devices › Syringes & needles · 12 Nov 2025 · 4 likes Filter needles are for drawing from glass ampoules where particulate is a real risk. For a stoppered vial they add dead volume in exchange for very little.
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #17 · Compounds › Oral incretins · 25 Oct 2025 · 0 likes Post #14 answers the question as asked. The question underneath it is different. Why administration conditions matter for oral semaglutide and not for injectables: the…
-
Compounds this community declines to help with, and why Replied, post #77 · Compounds › Other compounds · 7 Oct 2025 · 1 like The arithmetic in post #74 is right; the assumption feeding it is the part to check. PT-141 was developed from the same family with a different receptor profile, and it…
-
[2026 update] Long-time reader, first-time poster Replied, post #15 · Lounge › Introductions · 4 Oct 2025 · 1 like What I would tell a new member reading about Long-time reader for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #110 · Practice › Side effects · 1 Oct 2025 · 1 like This settles it for me, at least until somebody posts a reason it should not.
-
Availability by country, dated, with primary sources Replied, post #5 · Access › International · 28 Sep 2025 · 32 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #26 · Evidence › Preprints · 27 Sep 2025 · 0 likes Right, and stated more narrowly than I would have dared to state it.
-
What pooling buys you and what it destroys Replied, post #20 · Evidence › Meta-analyses · 12 Sep 2025 · 22 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
Appeal templates and why they are deliberately unemotional Replied, post #14 · Access › Insurance & coverage · 9 Sep 2025 · 7 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #9 · Clinical › Bloodwork · 8 Sep 2025 · 1 like A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Managing an unplanned gap in supply — what changed since Replied, post #43 · Access › Shortages · 21 Aug 2025 · 20 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information. The number is…
-
A request that was declined, and the reasoning — a second dataset Replied, post #19 · Documentation › Wiki requests · 7 Aug 2025 · 31 likes The commonest reason a good request stalls is that nobody converted it into a draft. A rough draft attracts editors; a request does not.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #80 · Compounds › Repair & healing peptides · 6 Aug 2025 · 4 likes On BPC-157 I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get…
-
A ten-fold dose error caught before injection — one year on Replied, post #91 · Devices › Syringes & needles · 3 Aug 2025 · 1 like Post #87 and I disagree about the size of the effect, not about the direction. Check what the graduations actually say rather than what you expect. A syringe marked in…
-
Temperature loggers worth the money — the long version Replied, post #13 · Devices › Cold chain · 18 Jul 2025 · 4 likes Post #11 put the caveat in the right place and I want to underline it. Small methodological point on Temperature loggers worth the money: repeating a measurement is…
-
A field-by-field walk through a certificate of analysis Replied, post #34 · Analytics › COA interpretation · 15 Jul 2025 · 0 likes This follows post #31 rather than contradicting it. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #70 · Evidence › Journal club · 7 Jul 2025 · 28 likes Sessions run better when the paper is circulated with three specific questions attached. Open-ended reading produces an open-ended discussion.
-
Request: a diff view for wiki revisions — the long version Replied, post #13 · Meta › Feature requests · 27 Jun 2025 · 6 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. Fair. Then under the name, at a smaller size, permanently.
-
What this community means by "a source", in practical terms Replied, post #16 · Start Here › Welcome · 26 Jun 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #144 · Access › Insurance & coverage · 16 Jun 2025 · 18 likes An honest declaration on appeal: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #63 · Compounds › Retatrutide · 11 Jun 2025 · 14 likes The most useful reply I ever got about Triple agonism was a request to state my units. It sounds like pedantry and it has saved me twice.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 7 Jun 2025 · 6 likes Post #28 is right about the mechanism and I think understates the practical bit. Is synergy the right word for the combination data? A phase 2 trial cannot establish…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #63 · Practice › Reconstitution · 3 Jun 2025 · 29 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #17 · Practice › Dosing & titration · 30 May 2025 · 2 likes Post #15 is the version of this I will quote in future. One addition. Dose and effect are not linear across the studied range for every compound in this class. Assuming…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #93 · Practice › Interactions · 20 May 2025 · 1 like Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is about rate and timing rather than about the total absorbed, in…
-
Coming back to: Official shortage notices and what they authorise Replied, post #10 · Access › Shortages · 20 May 2025 · 1 like Building on post #9 rather than restating it. Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to somebody who has run…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #40 · Compounds › Cagrilintide & amylin analogues · 9 May 2025 · 23 likes Building on post #37 rather than restating it. The strongest argument against my own position on cagrisema phase 2 paper, stated as well as I can state it, since nobody…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #74 · Clinical › Comorbidities · 3 May 2025 · 0 likes Post #73 is right about the mechanism and I think understates the practical bit. An observation about obstructive sleep apnoea that I cannot explain and am posting…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #4 · marked as the solution · Compounds › Oral incretins · 2 May 2025 · 7 likes On variability: the between-person spread in exposure for oral semaglutide is wide enough that two people on the same dose can have quite different plasma…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #42 · Wellbeing › Mental health · 29 Apr 2025 · 1 like History of disordered eating is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until…
-
Water content on a certificate and why it changes the arithmetic Replied, post #6 · Analytics › COA interpretation · 26 Apr 2025 · 0 likes The honest answer on water content is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #134 · Pharmacology › Receptor biology · 20 Mar 2025 · 28 likes Useful. I have added it to my own notes with the date on it.
-
Coverage for the indication versus for the drug — a second dataset Replied, post #23 · Access › Insurance & coverage · 17 Mar 2025 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #9 · Sourcing › Vendor reports · 15 Mar 2025 · 22 likes Recording a reorder result against the original is one of the highest-value contributions here, because consistency over time is what a single result cannot show.
-
Oxidation and deamidation mass shifts, tabulated Replied, post #62 · Analytics › Mass spectrometry · 27 Feb 2025 · 5 likes I had written a reply contradicting post #60 and deleted it. Here is what survived. Purity and identity are different questions: LC-MS establishes that the species at a…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #8 · Access › Pricing · 12 Feb 2025 · 10 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #46 · Clinical › Bloodwork · 6 Feb 2025 · 32 likes Lipid changes during substantial weight loss are expected and their trajectory is not always monotonic. A single mid-course panel can be misleading. Not disagreeing…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #5 · Clinical › Comorbidities · 28 Jan 2025 · 21 likes What I would check first on obstructive sleep apnoea is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #4 · Practice › Reconstitution · 16 Jan 2025 · 33 likes Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A 0.25 mg dose is 0.05 mL, which is five units on a U-100…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #18 · Practice › Interactions · 15 Jan 2025 · 0 likes Post #16 put the caveat in the right place and I want to underline it. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion,…
-
Follow-up: Individual participant data versus aggregate data Replied, post #29 · Evidence › Meta-analyses · 9 Jan 2025 · 1 like Reading back through, this was answered upthread and I missed it. My fault.
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #11 · Clinical › Bloodwork · 7 Jan 2025 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line.
-
Anxiety in the first weeks: drug, situation, or both Replied, post #32 · Wellbeing › Mental health · 29 Dec 2024 · 25 likes I came in to disagree and I am leaving without a disagreement.
-
Transit times by route, from a logged dataset — the long version Replied, post #43 · Sourcing › Logistics · 27 Dec 2024 · 4 likes Where the Transit times reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Fixed versus detachable needles: the trade-offs Replied, post #58 · Devices › Syringes & needles · 19 Dec 2024 · 0 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #117 · Clinical › Prescriber conversations · 7 Dec 2024 · 3 likes Understood, and I withdraw the assumption I opened with.
-
Converting between mg/mL and units per dose, both directions Replied, post #107 · Practice › Reconstitution · 28 Nov 2024 · 3 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Anyone who…
-
Promotion criteria, and the one that stops most nominations Replied, post #118 · Documentation › Doc review · 20 Nov 2024 · 0 likes Confirming post #115 from a second method, which matters more than confirming it from a second person. Offering a way to settle promotion criteria rather than another…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #18 · Compounds › Repair & healing peptides · 9 Nov 2024 · 22 likes Narrowing post #16, because the general version has more than one answer. The absence of adequately powered published randomised human trials is the central fact about…
-
Taste changes and food aversion, reported and discussed Replied, post #38 · Practice › Side effects · 8 Nov 2024 · 0 likes Building on post #35 rather than restating it. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #94 · Practice › Dosing & titration · 31 Oct 2024 · 1 like The strongest argument against my own position on four-week escalation interval, stated as well as I can state it, since nobody else has yet.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #30 · Compounds › Semaglutide · 22 Oct 2024 · 0 likes Where the Semaglutide half-life discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #2 · Sourcing › Independent verification · 17 Oct 2024 · 1 like Narrowing the opening post, because the general version has more than one answer. Repeat determination on the same product line months apart is the measurement that…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #47 · Access › Shortages · 10 Oct 2024 · 5 likes Reports that a pharmacy has stock are the least durable information on the site and are still worth posting with a date. A qualification I should have led with rather…
-
Converting between mg/mL and units per dose, both directions Replied, post #39 · Practice › Reconstitution · 4 Oct 2024 · 6 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. That matches…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #75 · Practice › Dosing & titration · 2 Oct 2024 · 8 likes An observation about four-week escalation interval that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #26 · Compounds › Tirzepatide · 2 Oct 2024 · 0 likes Post #23 is the version of this I will quote in future. One addition. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent…
-
Converting between mg/mL and units per dose, both directions Replied, post #10 · Practice › Reconstitution · 3 Sep 2024 · 2 likes Noted, and thank you for writing it out rather than summarising it.
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #16 · Analytics › Mass spectrometry · 12 Aug 2024 · 10 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Reporting a discrepancy without making an allegation Replied, post #8 · Sourcing › Vendor reports · 29 Jul 2024 · 7 likes Reporting a discrepancy is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #45 · Compounds › Retatrutide · 19 Jul 2024 · 16 likes Good question, well framed, and I would like to see it answered properly.
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #52 · Practice › Interactions · 16 Jul 2024 · 3 likes An honest declaration on oral contraceptives and delayed emptying: I have a prior here and it is strong enough that you should weight what I say downward. Stating it…
-
Cold packs, phase-change material, and what survives ten days Replied, post #93 · Sourcing › Logistics · 11 Jul 2024 · 18 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #122 · Practice › Dosing & titration · 10 Jul 2024 · 1 like Holding at a dose that is working is a legitimate position and it is not what the trial protocols did. The protocols escalated to a target because they were measuring…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #117 · Practice › Dosing & titration · 10 Jul 2024 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #4 · Practice › Interactions · 5 Jul 2024 · 21 likes I read the earlier replies on oral contraceptives and delayed emptying twice before writing this, because I had assumed the opposite and wanted to be sure I was…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #4 · Practice › Interactions · 28 Jun 2024 · 13 likes Post #3 is the version of this I will quote in future. One addition. Food interactions: most interactions are absorption interactions. Some medications absorb better…
-
Coming back to: Preparing for an appointment: one page, three questions Started this topic · Clinical › Prescriber conversations · 27 May 2024 · 0 likes Posting this under the heading it deserves: Preparing for an appointment: one page, three questions Everything below is what sits behind that. A question about how to…